CompletedPHASE1, PHASE2NCT00947635

Cholesterol and Fatty Acid Synthesis in Islet and Liver Transplant Patients and Effect of Dietary Intervention

Studying Acquired immunodeficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Alberta
Principal Investigator
Michael T Clandinin, PhD
University of Alberta
Intervention
Dietary intervention - supplements(dietary_supplement)
Enrollment
46 enrolled
Eligibility
18 years · All sexes
Timeline
20052009

Study locations (1)

Collaborators

Canadian Institutes of Health Research (CIHR)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00947635 on ClinicalTrials.gov

Other trials for Acquired immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Acquired immunodeficiency

← Back to all trials